(Q42661269)

4 November 2017

title

Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis (English)

1 reference

ORCID Public Data File 2021

4 November 2017

1 reference

1 reference

author name string

Sprinzl GM

1

1 reference

4 November 2017

Galvan O

2

1 reference

4 November 2017

de Vries A

3

1 reference

4 November 2017

Ulmer H

4

1 reference

4 November 2017

Gunkel AR

5

1 reference

4 November 2017

Lukas P

6

1 reference

4 November 2017

Thumfart WF

7

1 reference

4 November 2017

publication date

1 November 2001

1 reference

European Journal of Cancer

4 November 2017

published in

1 reference

4 November 2017

volume

37

1 reference

4 November 2017

issue

16

1 reference

4 November 2017

page(s)

2003-2009

1 reference

Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

The impact of antitumor therapy on nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Loss of local control with prolongation in radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Mucositis management practices for hospitalized patients: national survey results

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Local use of GM-CSF for severe mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Scoring oral mucositis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Randomized, placebo-controlled, multicenter trial of granulocyte-macrophage colony-stimulating factor as infection prophylaxis in oncologic surgery. Leukine Surgical Prophylaxis Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Oral sources of septicaemia in patients with malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Treatment-induced mucositis: an old problem with new remedies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemo-radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Granulocyte-macrophage colony-stimulating factor mouthwashes improve radiation induced mucositis in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Granulocyte macrophage-colony-stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900170-8

7 January 2021

10.1016/S0959-8049(01)00170-8

Identifiers

DOI

1 reference

4 November 2017

1 reference